Risk Factors of Death in Bloodstream Infections Caused by AmpC β-Lactamase-Producing Enterobacterales in Patients with Neoplasia

References

• ChaubeyVP, PitoutJDD, DaltonB, GregsonDB, RossT, LauplandKB. Clinical and microbiological characteristics of bloodstream infections due to AmpC β-lactamase producing Enterobacteriaceae: an active surveillance cohort in a large centralized Canadian region. BMC Infect Dis. 2014;14(1):647. doi:10.1186/s12879-014-0647-425494640
   PubMed Web of Science ®Google Scholar
• JacobyGA. AmpC β-lactamases. Clin Microbiol Rev. 2009;22(1):161–182. doi:10.1128/CMR.00036-0819136439
   PubMed Web of Science ®Google Scholar
• KangCI, KimSH, ParkWB, et al. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother. 2005;49(2):760–766. doi:10.1128/AAC.49.2.760-766.200515673761
   PubMed Web of Science ®Google Scholar
• GudiolC, TubauF, CalatayudL, et al. Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes. J Antimicrob Chemother. 2011;66:657–663. doi:10.1093/jac/dkq49421193475
   PubMed Web of Science ®Google Scholar
• Center for Disease Control and Prevention. Bloodstream infection event (central line-associated bloodstream infection and non-central line-associated bloodstream infection); 2020. Available from: http://www.cdc.gov/nhsn/. Acessed 715, 2020.
   Google Scholar
• MackenzieCRA new method of classifying prognostic comorbidity in longitudinal studies: development and validation; 1987. Available from: http://appliedresearch.cancer.gov/seermedicare/program/charlson.pdf. Accessed 514, 2015.
   Google Scholar
• FriedmanND, KayeKS, StoutJE, et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002;137(10):791–797. doi:10.7326/0003-4819-137-10-200211190-0000712435215
   PubMed Web of Science ®Google Scholar
• FreifeldAG, BowEJ, SepkowitzKA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America. Clin Infect Dis. 2011;52:e56–e93.21258094
   PubMed Web of Science ®Google Scholar
• GarridoM. Fatores De Risco Para Óbito Relacionado Às Infecções De Corrente Sanguínea Em Pacientes Pediátricos Com Doença Oncológica [Tese De Mestrado] [Risk factors of death related to bloodstream infection in pediatric patients with oncological disease [Master thesis]]. Rio de Janeiro: Instituto Nacional de Câncer José Alencar Gomes da Silva; 2017. Portuguese.
   Google Scholar
• MagiorakosAP, SrinivasanA, CareyRB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x21793988
   PubMed Web of Science ®Google Scholar
• VelascoE, ByingtonR, MartinsCSA, SchirmetM, DiasLCM, GonçalvesVMSC. Bloodstream infection surveillance in a cancer centre: a prospective look at clinical microbiology aspects. Clin Microbiol Infect. 2004;10(6):542–549. doi:10.1111/j.1469-0691.2004.00874.x15191383
   PubMed Web of Science ®Google Scholar
• AnatoliotakiM, ValatasV, MantadakisE, et al. Bloodstream infections in patients with solid tumors: associated factors, microbial spectrum and outcome. Infection. 2004;32(2):65–71. doi:10.1007/s15010-004-3049-515057569
   PubMed Web of Science ®Google Scholar
• McKameyL, VenugopalanV, CherabuddiK, et al. Assessing antimicrobial stewardship initiatives: clinical evaluation of cefepime or piperacillin/tazobactam in patients with bloodstream infections secondary to AmpC-producing organisms. Int J Antimicrob Agents. 2018;52(5):719–723. doi:10.1016/j.ijantimicag.2018.08.00730125680
   PubMed Web of Science ®Google Scholar
• MarínM, GudiolC, Garcia-VidalC, ArdanuyC, CarratalàJ. Bloodstream infections in patients with solid tumors: epidemiology, antibiotic therapy, and outcomes in 528 episodes in a single cancer center. Medicine. 2014;93(3):143–149. doi:10.1097/MD.000000000000002624797169
   PubMed Web of Science ®Google Scholar
• TanSH, NgTM, ChewKL, et al. Outcomes of treating AmpC-producing Enterobacterales bacteraemia with carbapenems vs. non-carbapenems. Int J Antimicrob Agents. 2020;55(2):105860. doi:10.1016/j.ijantimicag.2019.10586031841674
   PubMed Web of Science ®Google Scholar
• SievertDM, RicksP, EdwardsJR, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections summary of data reported to the national healthcare safety network at the centers for disease control and prevention, 2009–2010. Infect Control Hosp Epidemiol. 2013;34(1):1–14. doi:10.1086/66877023221186
   PubMed Web of Science ®Google Scholar
• LimCL, SpelmanD. Mortality impact of empirical antimicrobial therapy in ESBL- and AmpC-producing Enterobacteriaceae bacteremia in an Australian tertiary hospital. Infect Dis Health. 2019;24(3):124–133. doi:10.1016/j.idh.2019.02.00130928569
   PubMed Web of Science ®Google Scholar
• SostarichAM, ZolldannD, HaefnerH, LuettickenR, Schulze-RoebeckeR, LemmenSW. Impact of multiresistance of gram-negative bacteria in bloodstream infection on mortality rates and length of stay. Infection. 2008;36(1):31. doi:10.1007/s15010-007-6316-418231721
   PubMed Web of Science ®Google Scholar
• KadriSS, LaiYL, RicottaEE, et al. External validation of difficult-to-treat resistance prevalence and mortality risk in gram-negative bloodstream infection using electronic health record data from 140 US hospitals. Open Forum Infect Dis. 2019;6(4):ofz110. doi:10.1093/ofid/ofz11031240236
   PubMed Web of Science ®Google Scholar
• AitkenSL, FooladF, McDaneldPM. Should piperacillin-tazobactam be used as definitive therapy against Enterobacteriaceae harboring inducible AmpC β-lactamases?Antimicrob Agents Chemother. 2017;61(9):e01160–17. doi:10.1128/AAC.01160-1728839082
   PubMed Web of Science ®Google Scholar